Sato Yakuhin Kogyo Co., Ltd.
| Name | Sato Yakuhin Kogyo Co., Ltd. |
|---|---|
| Address | 9-2, Kannonji-Cho, Kashihara-City, Nara 634-8567 JAPAN |
| Phone | +81 (0)744-28-0021 |
| FAX | +81 (0)744-28-0030 |
| URL | http://www.sato-yakuhin.co.jp/ |
| Contact | Sales Division +81 (0)744-28-0022 (Direct) |
Our Strength
Sato Yakuhin Kogyo (SYK) launched its business for manufacturing capsules in 1960. In 1994, SYK acquired the first category license in Japan.
SYK is known for proactively conforming to regulations inside and outside Japan, such as the U.S. FDA and Health Canada standards.
With the support of clients, SYK currently manufactures about 170 pharmaceutical products for more than 60 major pharmaceutical companies. SYK has also launched service units for promoting business proposals and collaborative development of OTC drugs since 2014, and has since organized the business environment so they can respond to self-medication needs.
SKY operates its business under the motto: We will work with our whole hearts to win the trust of clients by creating a plant that produces better products, with faster delivery rates, and at more reasonable prices. SKY aims to meet the diverse needs of our clients and thereby grow into a leading contract manufacturing company.
[Dosage forms SYK can undertake for contract services]
Tablets, hard capsules, granules, powder, etc.
[Package form our service can provide]
PTP, pillowcase, four-sided seal, stick, SP, counting with filling jar, cartoning, etc.
[Strength of our services]
・Coating technology such as enteric or sustained release products
・Microparticle coating technology (including masking the effects of bitter ingredients for orally disintegrating tablets and incompatible ingredients)
・Fully capitalizing on filling technology for various types of capsules (hard types)
・Technological capacities to satisfy the demands for diverse package forms
・Capabilities of undertaking the whole package services from drug formulation study to commercial scale production.
・Proactive challenges to undertaking contract manufacturing of investigational products
